Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22450075 | 0.75 | DUT (0.34) | DUT | |
| SCHEMBL18868120 | 0.73 | DUT (0.31) | DUT | |
| SCHEMBL14554787 | 0.73 | DUT (0.31) | DUT | |
| SCHEMBL22007686 | 0.71 | — | — | |
| SCHEMBL7204990 | 0.70 | — | — | |
| SCHEMBL7000377 | 0.69 | MEN1 (0.41) | DUT | |
| SCHEMBL14739756 | 0.68 | DUT (0.34) | DUT | |
| SCHEMBL14554790 | 0.68 | DUT (0.32) | DUT | |
| SCHEMBL15369647 | 0.63 | DUT (0.30) | DUT | |
| SCHEMBL21389408 | 0.62 | DUT (0.36) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2751123-B1 | BIOCOMPATIBLE MATERIAL | VERTELLUS HOLDINGS LLC (US) | 2017-08-02 | — | — | EP | disclosed |
| US-9006305-B2 | Biocompatible material | VERTELLUS SPECIALTIES INC. (US) | 2015-04-14 | — | — | US | disclosed |
| US-9006305-B2 | Biocompatible material | VERTELLUS SPECIALTIES INC. (US) | 2015-04-14 | — | — | US | disclosed |
| US-8980956-B2 | Methods for producing biocompatible materials | VERTELLUS SPECIALITIES INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-8980956-B2 | Methods for producing biocompatible materials | VERTELLUS SPECIALITIES INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-8980956-B2 | Methods for producing biocompatible materials | VERTELLUS SPECIALITIES INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-20130059926-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VERTELLUS HOLDINGS, LLC | 2013-03-07 | — | — | US | disclosed |
| US-20130059926-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VERTELLUS HOLDINGS, LLC | 2013-03-07 | — | — | US | disclosed |
| US-20130059926-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VERTELLUS HOLDINGS, LLC | 2013-03-07 | — | — | US | disclosed |
| US-20130059970-A1 | BIOCOMPATIBLE MATERIAL | VERTELLUS HOLDINGS, LLC | 2013-03-07 | — | — | US | disclosed |
| US-20130059970-A1 | BIOCOMPATIBLE MATERIAL | VERTELLUS HOLDINGS, LLC | 2013-03-07 | — | — | US | disclosed |
| US-20130059970-A1 | BIOCOMPATIBLE MATERIAL | VERTELLUS HOLDINGS, LLC | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059970-A1 | BIOCOMPATIBLE MATERIAL | VCL, ITGAM, MACF1 | DUT 4636/4885 |
| US-20130059926-A1 | METHODS FOR PRODUCING BIOCOMPATIBLE MATERIALS | VCL, ECPAS, MACF1 | DUT 4521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.